Immunology In The News


  • – Stanford Medicine

    Stanford Medicine researchers tackle COVID-19

    Scientists at Stanford Medicine have launched dozens of research projects as part of the global response to COVID-19. Some aim to prevent, diagnose and treat the disease; others aim to understand how it spreads and how people’s immune systems respond to it. Read about the research launched by Kari Nadeau, MD, PhD, Catherine Blish, MD, PhD, Prasanna Jagannathan, MD, Michael Snyder, PhD, and Bali Pulendran, PhD.

  • – Washington Post

    Coronavirus will radically alter the U.S.

    At the heart of their algorithms is a scary but empowering truth: What happens next depends largely on us — our government, politicians, health institutions and, in particular, 328 million inhabitants of this country — all making tiny decisions on an daily basis with outsized consequences for our collective future. Karla Kirkegaard, the Violetta L. Horton Research Professor, chair and professor of microbiology and immunology, offers us how powerful the simple act of one individual can be.

  • – Washington Post

    Trump ban on fetal tissue research blocks coronavirus treatment effort

    An NIH scientist is appealing for permission to conduct covid-19 experiments with “humanized mice.” Irving Weissman, the Virginia and D.K. Ludwig Professor for Clinical Investigation in Cancer Research and director of Stanford’s Institute for Stem Cell Biology and Regenerative Medicine isn't sure this research method will find more effective treatments “but it’s stupid not to try.”

  • – Scope

    Improving cancer prognoses: A radio show

    This post highlights a recent segment of “The Future of Everything,” which featured Ash Alizadeh, associate professor of medicine oncology. He discussed how to improve cancer diagnosis and treatment, including using predictive modeling, liquid biopsies and immunotherapy with host Russ Altman, the Kenneth Fong Professor and professor of bioengineering, of genetics, of medicine and of biomedical data science.

  • – News Center

    Stanford scientists link ulcerative colitis to missing gut microbes

    Bacteria normally inhabiting healthy people’s intestines — and the anti-inflammatory metabolites these bacteria produce — are depleted in ulcerative colitis patients, a Stanford study shows. Senior author Aida Habtezion, associate professor of gastroenterology and hepatology, is quoted in this article. The research is also highlighted in a Stanford Medicine press release.